Folfox+Irinotecan+Chemort In Esophageal Cancer

Clinical trial NCT04656041 · RECRUITING

Trial details

NCT number: NCT04656041
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Junction Adenocarcinoma Esophagogastric Cancer

Start date: 2021-06-29
Primary completion: 2024-04-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.